These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 4843652

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Oncogenic osteomalacia in a 49-year-old female patient].
    Ludwig J, Mechtersheimer G, Haberkorn U, Nawroth P, Schilling T, Kasperk C.
    Dtsch Med Wochenschr; 2005 Feb 04; 130(5):206-9. PubMed ID: 15678388
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ, van der Kuy A, ter Wee PM, van Boven WP.
    Clin Nephrol; 1996 Feb 04; 45(2):111-9. PubMed ID: 8846523
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Johnson JR, George CR, Collett P, Kalowski S.
    Q J Med; 1985 May 04; 55(217):127-44. PubMed ID: 4001311
    [Abstract] [Full Text] [Related]

  • 52. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP, Heaf JG.
    Ugeskr Laeger; 1983 May 02; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract] [Full Text] [Related]

  • 53. [Phosphate deficiency as a rare cause of osteomalacia--case report of several years of enteral feeding and antacid therapy].
    Frieling I, Kruse HP, Wittig A, Beyer W, Delling G.
    Dtsch Med Wochenschr; 1998 Jul 24; 123(30):896-900. PubMed ID: 9711172
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
    Hill AV, Thein-Than, Cook DB, Derr KN, Latner AL.
    Clin Nephrol; 1973 Jul 24; 1(5):284-9. PubMed ID: 4797465
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
    Peacock M, Aaron JE, Heyburn PJ, Nordin BE.
    Adv Exp Med Biol; 1977 Jul 24; 81():431-40. PubMed ID: 899935
    [No Abstract] [Full Text] [Related]

  • 60. Osteomalacia after small-intestinal resection.
    Compston JE, Ayers AB, Horton LW, Tighe JR, Creamer B.
    Lancet; 1978 Jan 07; 1(8054):9-12. PubMed ID: 74542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.